Atlas Trials

Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men

Clinical trial NCT05636904 · COMPLETED

Trial details

NCT number
NCT05636904
Sponsor
Dermaliq Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Androgenetic Alopecia
Start date
2022-12-05
Primary completion
2024-03-28
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.